Afficher la couverture 'Synthesis of Pyridoclax Analogues: Insight into Their Druggability by Investigating Their Physicochemical Properties and Interactions with Membranes | de Pascale, Martina' en grand format
/5

0 avis

Synthesis of Pyridoclax Analogues: Insight into Their Druggability by Investigating Their Physicochemical Properties and Interactions with Membranes

Archive ouverte

de Pascale, Martina | Iacopetta, Domenico | Since, Marc | Corvaisier, Sophie | Vié, V. | Paboeuf, G. | Hennequin, Didier | Perato, Serge | de Giorgi, Marcella | Sinicropi, Maria Stefania | Santos, Jana Sopkova-de Oliveira | Voisin-Chiret, Anne-Sophie | Malzert-Fréon, Aurélie

Edité par CCSD ; Wiley-VCH Verlag -

International audience. Pyridoclax is considered a promising anticancer drug, acting as a protein-protein interaction disruptor, with potential applications in the treatment of ovarian, lung, and mesothelioma cancers. Eighteen sensibly selected structural analogues of Pyridoclax were synthesized, and their physicochemical properties were systematically assessed and analyzed. Moreover, considering that drug-membrane interactions play an essential role in understanding the mode of action of a given drug and its eventual toxic effects, membrane models were used to investigate such interactions in bulk (liposomes) and at the air-water interface. The measured experimental data on all original oligopyridines allowed the assessment of relative differences in terms of physicochemical properties, which could be determinant for their druggability, and hence for drug development.

Suggestions

Du même auteur

Design, synthesis and biological evaluation of protein-protein interactions disruptors, involved in apoptosis : applications to chemoresistant ovarian cancers. Conception, synthèse et évaluation biologique de perturbateurs d'interactions protéine-protéine impliquées dans l'apoptose : applications aux cancers de l'ovaire chimiorésistants

Archive ouverte | de Pascale, Martina | CCSD

Ovarian cancer is the 4th leading cause of cancer death in women. In France, nearly 4,500 new cases per year are diagnosed, with more than 3,000 deaths each year. This cancer remains silent for a long time: late diagnosis and chem...

Comparison of 2 strategies to enhance pyridoclax solubility: Nanoemulsion delivery system versus salt synthesis

Archive ouverte | Groo, Anne-Claire | CCSD

International audience. Pyridoclax is an original oligopyridine lead, very promising in treatment of chemoresistant cancers. However, from solubility measurement and permeability evaluation, it appeared that this co...

Structure-guided design of pyridoclax derivatives based on Noxa / Mcl-1 interaction mode

Archive ouverte | Hedir, Siham | CCSD

International audience. Protein-protein interactions are attractive targets because they control numerous cellular processes. In oncology, apoptosis regulating Bcl-2 family proteins are of particular interest. Apopt...

Chargement des enrichissements...